EZH2 and neoplasm: This effect is mediated through the targeting of enhancer of EZH2 and PXN (Sun J. et al., 2019; Jiang et al., 2018), thereby significantly modulating the behavior of tumor cells (Xu et al., 2014), resulting in inducing cell cycle arrest at G2/M.